State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
BGI Research, Shenzhen 518083, China
KMHD, Shenzhen 518000, China
Shenzhen Engineering Laboratory of Detection and Intervention of Human Intestinal Microbiome, BGI-Shenzhen, Shenzhen 518083, China
BGI-Sanya, BGI-Shenzhen, Sanya 572025, China
Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen 2100, Denmark
Shenzhen Key Laboratory of Environmental Microbial Genomics and Application, BGI-Shenzhen, Shenzhen 518083, China
†These authors contributed equally to this work.
Show Author Information
Hide Author Information
Highlights
(1) Identification and characterization of herbs with anti-obesity effects and investigate their interactions with the gut microbiota.
(2) Inulin, Mori follum, Corn silk, Maydis seigma, Crataegus, Taraxacum, Portulacae herba, Rhizoma gastrodiae, Rose rugosae flos, and Thallus laminariae significantly reduce body weight and restore gut microbiota dysbiosis in high-fat diet-induced obesity.
(3) Specific bacteria enriched by anti-obesity herbs, such as Blautia, are inversely related to triglyceride levels, while Desulfovibrio, reduced by the herbs, is positively associated with weight gain.
(4) Arachidonic acid, shared by three anti-obesity herbs, is linked to beneficial bacteria like Blautia.
(5) These findings advance our understanding of the regulatory network between herbs and the gut microbiota, offering potential targets for future interventions.
Graphical Abstract
A high-fat diet-induced obesity mouse model was employed to assess the efficacy of various herbs in weight reduction and investigate their interactions with the gut microbiota.
Abstract
Obesity, a pervasive global public health challenge, impacts human well-being, and there is a growing interest in the potential of herbs for their anti-obesity effects. However, the specific herbs that possess these properties are not well understood. This study aims to identify and characterize herbs that promote weight loss and to elucidate the mechanisms involved. We employed a high-fat diet (HFD)-induced obesity mouse model to assess the efficacy of various herbs in weight reduction and to explore how these herbs interact with the gut microbiota. By leveraging the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), we identified active ingredients present in the herbs and analyzed their regulatory effects on the gut microbiota. Among the 65 herbs, inulin, mori follum, corn silk, maydis seigma, crataegus, taraxacum, portulacae herba, rhizoma gastrodiae, rose rugosae flos, thalluslaminariae were found to significantly reduce body weight and restore the gut microbiota dysbiosis associated with HFD-induced obesity. We found that Blautia, which was enriched by the anti-obesity herbs, was inversely related to triglyceride (TG) levels. Conversely, Desulfovibrio, reduced by the anti-obesity herbs, was a positively linked to weight and weight gain. Furthermore, we discovered that arachidonic acid, shared by three anti-obesity herbs, was associated with beneficial bacteria such as Blautia. Our study identified 10 herbs with anti-obesity properties, detailing their active constituents and their influence on the gut microbiota. Our finding not only identified nearly 10 herbs that significantly reduce body weight, but also contribute to improving the understanding of the regulatory network between herbs and the gut microbiota.
No abstract is available for this article. Click the button above to view the PDF directly.
Electronic Supplementary Material
Download File(s)
FMH-2025-9420034_ESM.pdf (1.4 MB)
References
[1]
Malik, V. S., Hu, F. B. The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases. Nature Reviews Endocrinology, 2022, 18: 205–218. https://doi.org/10.1038/s41574-021-00627-6
Rodrigo, S. C., Santiago, N. C., Miguel Ángel, M. G., et al. Contribution of macronutrients to obesity: implications for precision nutrition. Nature Reviews Endocrinology, 2020 : 8. https://doi.org/10.1038/s41574-020-0346-8
Cremonini, E., Daveri, E., Mastaloudis, A., et al. Anthocyanins protect the gastrointestinal tract from high fat diet-induced alterations in redox signaling, barrier integrity and dysbiosis. Redox Biology, 2019, 26: 101269. https://doi.org/10.1016/j.redox.2019.101269
Jalileh, J., Ghasemzadeh Rahbardar, M. Ameliorative effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: a review. Journal of Ethnopharmacology, 2022 : 115672. https://doi.org/10.1016/j.jep.2022.115672
Xu, X., Yu, L., Chen, G. Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis, 2006, 41: 493–499. https://doi.org/10.1016/j.jpba.2006.01.013
Park, J. E., Han, J. S. A Portulaca oleracea L. extract promotes insulin secretion via a K+ATP channel dependent pathway in INS-1 pancreatic β-cells. Nutrition Research and Practice, 2018, 12: 183. https://doi.org/10.4162/nrp.2018.12.3.183
Darvish Damavandi, R., Shidfar, F., Najafi, M., et al. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial. Phytotherapy Research, 2021, 35: 3145–3156. https://doi.org/10.1002/ptr.6972
Samah, A. E. N. The hypolipidemic effect of Portulaca oleracea L. stem on hyperlipidemic Wister Albino rats. Annals of Agricultural Science, 2016, 61: 111–124. https://doi.org/10.1016/j.aoas.2016.01.002
Aliniya, N., Elmieh, A., Fadaei Chafy, M. The effect of combined training and portulaca oleracea supplementation on plasma lipid profile and liver ultrasound in obese females with nonalcoholic fatty liver disease. Journal of Arak University of Medical Sciences, 2020 : 92–107. https://doi.org/10.32598/JAMS.23.1.5910.2
Cho, I. J., Kim, S. E., Choi, B. R., et al. Lemon balm and corn silk extracts mitigate high-fat diet-induced obesity in mice. Antioxidants, 2021, 10: 1–16. https://doi.org/10.3390/antiox10122015
Wang, Z., Lu, J., Zhou, J., et al. Modulation of the gut microbiota by Shen-Yan-Fang-Shuai formula improves obesity induced by high-fat diets. Frontiers in Microbiology, 2020, 11: 564376. https://doi.org/10.3389/fmicb.2020.564376
Yue, S. J., Wang, W. X., Yu, J. G., et al. Gut microbiota modulation with traditional Chinese medicine: a system biology-driven approach. Pharmacological Research, 2019, 148: 104453. https://doi.org/10.1016/j.phrs.2019.104453
Feng, W., Ao, H., Peng, C., et al. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacological Research, 2019, 142: 176–191. https://doi.org/10.1016/j.phrs.2019.02.024
Zhang, B., Yue, R., Chen, Y., et al. Gut microbiota, a potential new target for chinese herbal medicines in treating diabetes mellitus. Evidence-Based Complementary and Alternative Medicine, 2019, 2019: 1–11. https://doi.org/10.1155/2019/2634898
Mulders, R. J., de Git, K. C. G., Schéle, E., et al. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems: microbiota in obesity. Obesity Reviews, 2018, 19: 435–451. https://doi.org/10.1111/obr.12661
Lin, T. L., Lu, C. C., Lai, W. F., et al. Role of gut microbiota in identification of novel TCM-derived active metabolites. Protein & Cell, 2021, 12: 394–410. https://doi.org/10.1007/s13238-020-00784-w
Asnicar, F., Berry, S. E., Valdes, A. M., et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nature Medicine, 2021, 27: 321–332. https://doi.org/10.1038/s41591-020-01183-8
Madsen, L., Myrmel, L. S., Fjære, E., et al. Links between dietary protein sources, the gut microbiota, and obesity. Frontiers in Physiology, 2017, 8: 1047. https://doi.org/10.3389/fphys.2017.01047
Zheng, Y., Ding, Q., Wei, Y., et al. Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: a systematic review and meta-analysis. Phytomedicine, 2021, 88: 153455. https://doi.org/10.1016/j.phymed.2020.153455
Shang, A., Gan, R. Y., Xu, X. Y., et al. Effects and mechanisms of edible and medicinal plants on obesity: an updated review. Critical Reviews in Food Science and Nutrition, 2021, 61: 2061–2077. https://doi.org/10.1080/10408398.2020.1769548
Bolyen, E., Rideout, J. R., Dillon, M. R., et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature Biotechnology, 2019, 37: 852–857. https://doi.org/10.1038/s41587-019-0209-9
Liu, J., He, Z., Ma, N., et al. Beneficial effects of dietary polyphenols on high-fat diet-induced obesity linking with modulation of gut microbiota. Journal of Agricultural and Food Chemistry, 2020, 68: 33–47. https://doi.org/10.1021/acs.jafc.9b06817
Wu, L., Park, S. H., Kim, H. Direct and indirect evidence of effects of Bacteroides spp. on obesity and inflammation. International Journal of Molecular Sciences, 2023, 25: 438. https://doi.org/10.3390/ijms25010438
Lai, Z. L., Tseng, C. H., Ho, H. J., et al. Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice. Scientific Reports, 2018, 8: 15625. https://doi.org/10.1038/s41598-018-33893-y
Liu, R., Hong, J., Xu, X., et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nature Medicine, 2017, 23: 859–868. https://doi.org/10.1038/nm.4358
Sun, L., Xie, C., Wang, G., et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nature Medicine, 2018, 24: 1919–1929. https://doi.org/10.1038/s41591-018-0222-4
Yi, X., Cai, R., Shaoyong, W., et al. Melatonin promotes gut anti-oxidative status in perinatal rat by remodeling the gut microbiome. Redox Biology, 2023, 65: 102829. https://doi.org/10.1016/j.redox.2023.102829
Pinart, M., Dötsch, A., Schlicht, K., et al. Gut microbiome composition in obese and non-obese persons: a systematic review and meta-analysis. Nutrients, 2021, 14: 12. https://doi.org/10.3390/nu14010012
Chang, C. J., Lin, C. S., Lu, C. C., et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature Communications, 2015, 6: 7489. https://doi.org/10.1038/ncomms8489
Wu, T. R., Lin, C. S., Chang, C. J., et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut, 2019, 68: 248–262. https://doi.org/10.1136/gutjnl-2017-315458
Lyu, M., Wang, Y., Fan, G., et al. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Frontiers in Microbiology, 2017, 8: 2146. https://doi.org/10.3389/fmicb.2017.02146
Tong, X., Xu, J., Lian, F., et al. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. mBio, 2018, 9: e02392–17. https://doi.org/10.1128/mBio.02392-17
Nie, Q., Chen, H., Hu, J., et al. Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota. Critical Reviews in Food Science and Nutrition, 2019, 59: 848–863. https://doi.org/10.1080/10408398.2018.1536646
Wang, P., Gao, J., Ke, W., et al. Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota. Free Radical Biology and Medicine, 2020, 156: 83–98. https://doi.org/10.1016/j.freeradbiomed.2020.04.013
Arnoriaga-Rodríguez, M., Mayneris-Perxachs, J., Burokas, A., et al. Gut bacterial ClpB-like gene function is associated with decreased body weight and a characteristic microbiota profile. Microbiome, 2020, 8: 59. https://doi.org/10.1186/s40168-020-00837-6
Hiel, S., Gianfrancesco, M. A., Rodriguez, J., et al. Link between gut microbiota and health outcomes in inulin-treated obese patients: lessons from the Food4Gut multicenter randomized placebo-controlled trial. Clinical Nutrition, 2020, 39: 3618–3628. https://doi.org/10.1016/j.clnu.2020.04.005
Vliex, L. M. M., Le, G. N., Fassarella, M., et al. Fecal carriage of vanB antibiotic resistance gene affects adipose tissue function under vancomycin use. Gut Microbes, 2022, 14: 2083905. https://doi.org/10.1080/19490976.2022.2083905
Singh, H., Torralba, M. G., Moncera, K. J., et al. Gastro-intestinal and oral microbiome signatures associated with healthy aging. GeroScience, 2019, 41: 907–921. https://doi.org/10.1007/s11357-019-00098-8
Telle-Hansen, V. H., Gaundal, L., Høgvard, B., et al. A three-day intervention with granola containing cereal beta-glucan improves glycemic response and changes the gut microbiota in healthy individuals: a crossover study. Frontiers in Nutrition, 2022, 9: 796362. https://doi.org/10.3389/fnut.2022.796362
Dantas Machado, A. C., Brown, S. D., Lingaraju, A., et al. Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome. Cell Reports, 2022, 40: 111008. https://doi.org/10.1016/j.celrep.2022.111008
Hwaung, P., Bosy-Westphal, A., Muller, M. J., et al. Obesity tissue: composition, energy expenditure, and energy content in adult humans. Obesity, 2019 : oby.22557. https://doi.org/10.1002/oby.22557
Gotoh, K., Inoue, M., Masaki, T., et al. Obesity-related chronic kidney disease is associated with spleen-derived IL-10. Nephrology Dialysis Transplantation, 2013, 28: 1120–1130. https://doi.org/10.1093/ndt/gfs440
Gotoh, K., Fujiwara, K., Anai, M., et al. Role of spleen-derived IL-10 in prevention of systemic low-grade inflammation by obesity [review]. Endocrine Journal, 2017, 64: 375–378. https://doi.org/10.1507/endocrj.EJ17-0060
Pi-Sunyer, F. X. The obesity epidemic: pathophysiology and consequences of obesity. Obesity Research, 2002, 10: 97S–104S. https://doi.org/10.1038/oby.2002.202
Cox, A. J., West, N. P., Cripps, A. W. Obesity, inflammation, and the gut microbiota. The Lancet Diabetes & Endocrinology, 2015, 3: 207–215. https://doi.org/10.1016/S2213-8587(14)70134-2
Chen, J., Xiao, Y., Li, D., et al. New insights into the mechanisms of high-fat diet mediated gut microbiota in chronic diseases. iMeta, 2023 : 69. https://doi.org/10.1002/imt2.69
Musso, G., Gambino, R., Cassader, M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annual Review of Medicine, 2011, 62: 361–380. https://doi.org/10.1146/annurev-med-012510-175505
Ridaura, V. K., Faith, J. J., Rey, F. E., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 2013, 341: 1241214. https://doi.org/10.1126/science.1241214
Zhu, W., Gregory, J. C., Org, E., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell, 2016, 165: 111–124. https://doi.org/10.1016/j.cell.2016.02.011
Virtue, A. T., McCright, S. J., Wright, J. M., et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Science Translational Medicine, 2019, 11: eaav1892. https://doi.org/10.1126/scitranslmed.aav1892
Zhou, M., Johnston, L. J., Wu, C., et al. Gut microbiota and its metabolites: bridge of dietary nutrients and obesity-related diseases. Critical Reviews in Food Science and Nutrition, 2021 : 1–18. https://doi.org/10.1080/10408398.2021.1986466
Benítez-Páez, A., Gómez del Pugar, E. M., López-Almela, I., et al. Depletion of Blautia species in the microbiota of obese children relates to intestinal inflammation and metabolic phenotype worsening. mSystems, 2020, 5: e00857–19. https://doi.org/10.1128/mSystems.00857-19
Henneke, L., Schlicht, K., Andreani, N. A., et al. A dietary carbohydrate–gut Parasutterella–human fatty acid biosynthesis metabolic axis in obesity and type 2 diabetes. Gut Microbes, 2022, 14: 2057778. https://doi.org/10.1080/19490976.2022.2057778
Thingholm, L. B., Rühlemann, M. C., Koch, M., et al. obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host & Microbe, 2019 , 26: 252–264. https://doi.org/10.1016/j.chom.2019.07.004
Perry, R. J., Peng, L., Barry, N. A., et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature, 2016, 534: 213–217. https://doi.org/10.1038/nature18309
Chen, C., You, L. J., Huang, Q., et al. Modulation of gut microbiota by mulberry fruit polysaccharide treatment of obese diabetic db/ db mice. Food & Function, 2018, 9: 3732–3742. https://doi.org/10.1039/ C7FO01346A
Sang, T., Guo, C., Guo, D., et al. Suppression of obesity and inflammation by polysaccharide from sporoderm-broken spore of Ganoderma lucidum via gut microbiota regulation. Carbohydrate Polymers, 2021, 256: 117594. https://doi.org/10.1016/j.carbpol.2020.117594
Xu, Y., Wang, N., Tan, H. Y., et al. Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin-mediated AMPKα/STAT3 signaling in diet-induced obesity. Theranostics, 2020 , 10: 11302–11323. https://doi.org/10.7150/thno.47746
Liao, P., Wang, W., Wang, W., et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell, 2022, 40: 365–378. https://doi.org/10.1016/j.ccell.2022.02.003
Xue, G., Zheng, Z., Liang, X., et al. Uterine tissue metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in mice with endometritis and the intervention effect of tau interferon. Microbiology Spectrum, 2023 : e00409-23. https://doi.org/10.1128/spectrum.00409-23
Shi, H., Li, X., Hou, C., et al. Effects of pomegranate peel polyphenols combined with inulin on gut microbiota and serum metabolites of high-fat-induced obesity rats. Journal of Agricultural and Food Chemistry, 2023, 71: 5733–5744. https://doi.org/10.1021/acs.jafc.3c01014
Lu, Y. M., Xie, J. J., Peng, C. G., et al. Enhancing clinical efficacy through the gut microbiota: a new field of traditional Chinese medicine. Engineering, 2019, 5: 40–49. https://doi.org/10.1016/j.eng.2018.11.013
Liu Y-M, Liu C, Deng Y-S, et al. Beneficial effects of dietary herbs on high-fat diet-induced obesity linking with modulation of gut microbiota. Food & Medicine Homology, 2025, 2(2): 9420034. https://doi.org/10.26599/FMH.2025.9420034
京公网安备11010802044758号